4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-22-002748
CEO sold 3,718 shares at $23.05 ($85,700)
- CEO acquired 9,527 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2022-01-06 | Option exercise | +9,527 | 62,434 | D | ||
| DAVIS STEPHEN CEO | 2022-01-06 | Sale | −3,718 | $23.05 | $85,700 | 58,716 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2022-01-06 | Option exercise · Restricted Stock Units | −9,527 | 19,056 | D | ||
| Open-market sales · 3,718 sh · avg $23.05 · $85,700 | |||||||
Loading xslF345X03/doc4.xml…